Bioassays: Universal sensitivity booster
Crossref DOI link: https://doi.org/10.1038/s41551-017-0088
Published Online: 2017-06-13
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kelley, Shana O.
Text and Data Mining valid from 2017-06-13
Version of Record valid from 2017-06-13
Article History
First Online: 13 June 2017
Competing interests
: S.O.K. has filed patents on diagnostic technologies and is a shareholder of Xagenic Inc., a company developing clinical diagnostics.